News & Analysis as of

Congressional Investigations & Hearings Centers for Disease Control and Prevention (CDC) Vaccinations

Holland & Knight LLP

Holland & Knight Health Dose: July 15, 2025

Holland & Knight LLP on

The U.S. House of Representatives returns from a district work period. The U.S. Senate is expected to consider the $9.4 billion rescissions package that passed the House last month. If not passed by July 18, 2025, the...more

Holland & Knight LLP

Holland & Knight Health Dose: June 6, 2023

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more

Holland & Knight LLP

Holland & Knight Health Dose: May 9, 2023

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics include ... ...more

Alston & Bird

Alston & Bird Health Care Week in Review - February 2022 #2

Alston & Bird on

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, April 2021 # 8

Hogan Lovells on

In Washington: On Tuesday, the Centers for Disease Control and Prevention (CDC) eased its guidelines on wearing masks outdoors, saying fully vaccinated Americans don’t need to mask up unless they are in certain crowded...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, April 2021

Hogan Lovells on

In Washington: Congress returns this week from their two-week spring recess.   The Senate will continue its consideration of President Biden’s health care nominees.   On April 15, the Senate Finance Committee will consider...more

Hogan Lovells

Coronavirus: The Hill and the Headlines – COVID-19 D.C. Update – September 2020 # 16

Hogan Lovells on

In Washington - President Trump announced a plan Monday to deploy 150 million rapid tests to states and vulnerable communities. This comes one month after the administration initially announced the purchase. During a Rose...more

Hogan Lovells

Coronavirus: The Hill and the Headlines – COVID-19 D.C. Update – September 2020 # 13

Hogan Lovells on

In Washington - Trump health administration officials testified Wednesday before the Senate Health, Education, Labor, and Pensions Committee on the nation's response to the COVID-19 pandemic. Dr. Anthony Fauci of the NIH,...more

Hogan Lovells

Coronavirus: The Hill and the Headlines – COVID-19 D.C. Update – September 2020 # 12

Hogan Lovells on

In Washington - House Democrats postponed a planned Tuesday to vote on a bill to keep the government funded through 11 Dec. as talks resume with Republicans and the Trump administration....more

Hogan Lovells

Coronavirus: The Hill and the Headlines – COVID-19 D.C. Update – September 2020 # 10

Hogan Lovells on

In Washington - On Friday, the CDC reversed its guidance advising that it was unnecessary to test people without symptoms of COVID-19. The change came after it was revealed that CDC scientists did not write it. The...more

WilmerHale

Weekly COVID-19 Oversight & Enforcement Report - August 2020 #3

WilmerHale on

House Select Subcommittee on the Coronavirus Crisis Chairman Jim Clyburn (D-SC) sent letters to HHS Secretary Alex Azar, Operation Warp Speed Chief Advisor Dr. Moncef Slaoui, and David S. Harris, President and CEO of Advanced...more

Hogan Lovells

Coronavirus: The Hill and the Headlines – COVID-19 D.C. Update – May 2020 #10

Hogan Lovells on

In Washington: The House of Representatives passed H.R. 6800, “The HEROES Act” 208-199.  Some moderates and progressive members shared concerns about the measure; progressives felt like the bill did not go far enough,...more

12 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide